Our new FV is MYR1.00 (on 19.2x CY15 PER).
Main Market transfer , M&As are further re-rating catalysts.
IFCA’s 3Q14 net profit of MYR8.5m (+445% YoY, +184% QoQ) took 9M14 earnings to MYR12m (+631% YoY). The underlying strength in 9M14 earnings came from net margin expansion (+16ppt YoY) as revenue growth (+53% YoY) on better pricing power and higher number of new customers surpassed cost expansion (+12%). Revenue growth in turn came mainly from the overseas markets (+63.6% YoY ; mainly from China) vs. Malaysia (+49% YoY).
As at Sep 2014, IFCA has secured MYR84m in sales contracts, meeting 84% of its FY14 sales target of MYR100m. Its balance sheet remains clean with a net cash of MYR34.7m or 8sen/sh.
We now expect higher FY14/15 earnings by +125%/+132% compared to our earlier projections in our note on 25 Aug 2014. This factors in: 1) a stronger-than-expected net margin of 25% (previously 13%) and 2) a higher sales contract target of MYR110m for 2014 (+10%), but 3) a lower 2015 sales target of MYR130m (-13%). IFCA is now in its growth phase and is reaping the fruits from its aggressive expansion in China over the past ten years.
Pegging IFCA to 19.2x CY15 PER (on an unchanged 10% discount to sector average), our new fully diluted fair value for IFCA is MYR1.00 (+58sen). We were the first to discover this underresearched gem. Since our report dated 25 Aug 2014, share price has performed strongly +162.3%. Even so, there is still +42% upside based on our new FV .
Source: Maybank Research - 6 Nov 2014
Chart | Stock Name | Last | Change | Volume |
---|
jehovahnissi
go up up
2014-11-06 10:15